Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study
Go back to Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study| (NASDAQ: BDSX) | Delayed: 26.97 +0.93 (3.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.04 | 52 Week High | $ | |||
| Open | $26.12 | 52 Week Low | $ | |||
| Day High | $27.14 | P/E | N/A | |||
| Day Low | $25.82 | EPS | $ | |||
| Volume | 46,440 | |||||

